These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7709471)

  • 21. [Prognosis of yeast cells recovery after simultaneous exposure to UV-radiation and hyperthermia].
    Komarova LN; Tkhabisimova MD; Petin VG
    Tsitologiia; 2007; 49(1):83-8. PubMed ID: 17432612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermia-induced increase in potassium transport in Chinese hamster cells.
    Stevenson AP; Galey WR; Tobey RA; Stevenson HG; Jett JH
    J Cell Physiol; 1983 Apr; 115(1):75-86. PubMed ID: 6833410
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mathematical description of synergistic interactions of environment temperature and microwaves for animal warming].
    Kalugina AV; Komarova LN; Petin VG
    Radiats Biol Radioecol; 2002; 42(2):223-7. PubMed ID: 12004623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivo.
    Papadopoulou MV; Ji M; Bloomer WD
    In Vivo; 1996; 10(1):49-57. PubMed ID: 8726811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A dynamic study of the cytotoxic effects of hyperthermia combined with cis-diaminedichlorolplatinum (DDP) on human gastric cancer cell lines MKN28 and MKN45 in vitro].
    Chen W; Ji F; Huang H
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):116-8. PubMed ID: 9206043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
    Dorie MJ; Brown JM
    Cancer Res; 1993 Oct; 53(19):4633-6. PubMed ID: 8402639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system.
    Masuda H; Tanaka T; Matsushima S
    Anticancer Res; 1998; 18(3A):1473-7. PubMed ID: 9673358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of actio of poly-plat, a novel platinum antineoplastic agent.
    Telgenhoff DJ; Aggarwal SK
    Anticancer Res; 2002; 22(4):2167-72. PubMed ID: 12174899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
    Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
    Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of cis-DDP and pyridoxal effect on isolated DNA during simultaneous application.
    Rauko P; Novotný L; Balázová E
    Neoplasma; 1993; 40(5):283-8. PubMed ID: 8272156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II.
    Urano M; Kahn J; Kenton LA
    Int J Hyperthermia; 1990; 6(3):563-70. PubMed ID: 2376669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro].
    Wang XG; Fu J; Zheng H; Li GX; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1487-90. PubMed ID: 17062359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents.
    Papadopoulou MV; Bloomer WD
    In Vivo; 2007; 21(2):175-80. PubMed ID: 17436565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.